PPARgamma Deacetylation in the Restoration of Metabolic Homeostasis
Description: This project addresses a major unmet clinical need by investigating a mechanism to activate nuclear receptor PPARγ and leverage its insulin-sensitizing properties for the treatment of insulin resistance and diabetes, while preventing the adverse effects of PPARγ agonists on the body weight, cardiovascular system, bone, and fluid balance.
Funding type: research
Funder scheme: R01
Start date: 2017-12-01
End date: 2022-11-30
Investigator: LI QIANG
Institution: COLUMBIA UNIVERSITY HEALTH SCIENCES
Subfield: Molecular Biology
Domain: Life Sciences
Funded outputs count: 21
Funder award ID: R01DK112943
OpenAlex ID: G4157717153
